Ming Yang
Analyst · ROTH Capital Partners. Please go ahead
Thank you, Longgen and good day, everyone. Thank you for joining our earnings conference call today. And this is Ming Yang, I'm the CFO of the company. We are very pleased to report an excellent financial performance for the third quarter of 2021. We had record high revenues of $585.8 million, an increase of 33% sequentially as compared to $441.4 million in the second quarter of 2021 and an increase of 366% year-over-year as compared to $125.5 million in the third quarter of 2020. The increase in revenue as compared to the second quarter of 2021 as well as the third quarter of 2020 was primarily due to higher polysilicon average selling prices and higher polysilicon sales volume. During the third quarter, market conditions for solar remained robust with strong demand for mono-grade polysilicon that far exceeded supply. Our third quarter polysilicon ASP was $27.55 per kilogram, an increase of 32% sequentially as compared to ASP of $20.81 per kilogram in the second quarter. Gross profit was $435.2 million compared to $303.2 million in the second quarter of 2021 and $45.3 million in the third quarter of 2020. Gross margin was 74.3% compared to 68.7% in the second quarter of 2021 and 36% in the third quarter of 2020. The increase in gross margin was primarily due to higher average selling prices, offset by slightly higher production costs. As Longgen indicated, higher production costs during Q3 was the result of higher market price for silicon raw material. Selling, general and administrative expenses were $11.4 million compared to $9.3 million in the second quarter of 2021 and $9.2 million in the third quarter of 2020. SG&A expenses during the quarter included $2 million in non-cash share-based compensation costs related to the company's share incentive plan, compared to $2 million in the second quarter of 2021 and $4 million in the third quarter of 2020. The increase as compared to the second quarter of 2021 as well as the third quarter of 2020 was primarily due to expenses related to the IPO of our Xingjiang Daqo subsidiary on China's Asia market. R&D expenses were $1.9 million compared to $2.1 million in the second quarter of 2021 and $1.7 million in the third quarter of 2020. R&D expenses converted from period-to-period and reflect R&D activities that take place during the quarter. As a result of the foregoing, income from operations was $421.7 million compared to $292.4 million in the second quarter of 2021 and $33.3 million in the third quarter of 2020. Operating margin was 72% compared to 66.3% in the second quarter of 2021 and 26.6% in the third quarter of 2020. Interest expense was $6.4 million compared to $7.2 million in the second quarter of 2021 and $5.4 million in the third quarter of 2020. Net income was $255.8 million compared to $242.9 million in the second quarter of 2021 and $21.9 million in the third quarter of 2020. Adjusted for minority interests, net income attributable to Daqo New Energy Corp. shareholders was $292.3 million compared to $232.1 million in the second quarter of 2021 and $20.8 million in the third quarter of 2020. Earnings per basic ADS was $3.95 compared to $3.15 in the second quarter of 2021 and $0.29 in the third quarter of 2020. EBITDA was $441.8 million compared to $311.7 million in the second quarter of 2021 and $51.6 million in the third quarter of 2020. EBITDA margin was 75.4% compared to 70.6% in the second quarter of 2021 and 41.1% in the third quarter of 2020. Now on the company's balance sheet and financial conditions. As disclosed previously, the company successfully completed the IPO listing of it's Xingjiang Daqo subsidiary on China's Asia market in July 2021. Net proceeds of the IPO, minus listing related expenses are approximately RMB 6.1 million or approximately USD935 million which will fund Xingjiang Daqo's polysilicon expansion project and provide additional capital for the company's future growth plans. Following Xingjiang Daqo's IPO, Daqo New Energy in aggregate holds approximately 80.7% of the A share listed subsidiary. As of September 30, 2021, the company had $660.9 million in cash and cash equivalents and restricted cash compared to $269.7 million as of June 30, 2021 and $109.8 million as of September 30, 2020. To better utilize the company's cash balance with improved capital efficiency, the company purchased short-term investments during the quarter which are primarily principal protected short-term interest bearing bank deposits with 3-month and 6-month maturity duration. These term deposits have higher interest rate than the regular bank deposit accounts. As such, at the end of the quarter, the company had $414.2 million in short-term investments compared to $10.4 million as of June 30, 2021. And as of September 30, 2021, bank notes receivable balance was $353.3 million compared to $97 million as of June 30, 2021 and $1.9 million as of September 30, 2020. Inclusive of our cash and cash equivalents, short-term investments and bank note receivable balance, the company has total capital liquidity of approximately $1.43 billion as of September 30, 2021. With our strong cash balance, we also took the opportunity to repay all of our bank borrowings at the end of the quarter. And as of September 30, 2021, we had no bank borrowings compared to total borrowings of $156.6 million as of June 30, 2021 and total borrowings of $271 million as of September 30, 2020. For the nine months ended September 30, 2021, with our strong earnings, operating cash flow and cash balance, we repaid approximately $195 million of bank borrowings. And with our total capital liquidity of $1.43 billion and no interest-bearing bank loans, we now have what we believe to be one of the best balance sheets in the industry. And combined with the ability to access the attractive Asia capital markets in China, we are very well positioned competitively for our company's future growth and expansion plans. For the nine months ended September 30, 2021, net cash provided operating activities was $653 million compared to $71 million in the same period of 2020. The increase was primarily due to higher ASPs and higher polysilicon sales volume as well as prepayments of long-term contracts from customers. And for the nine months ended September 30, 2021, net cash used in investing activities was $855 million compared to $80.3 million in the same period of 2020. The net cash using investing activities in 2021 and 2020 was primarily related to the capital expenditures on the company's polysilicon expansion projects. Purchase of property, plant, equipment and land totaled approximately $444 million in the first nine months of the year, primarily related to our Phase 4B polysilicon expansion project. The remaining balance was primarily related to the company's purchase of short-term investments. For the nine months ended September 30, 2021, net cash provided by financing activities was $741.6 million compared to $1.1 million in the same period of 2020. The net cash provided by financing activities in 2021 was primarily related to the net proceeds of $935 million, contributed by Xingjiang Daqo's IPO in China, offset by net repayments of bank borrowings. And that concludes our prepared remarks. Operator, now we would like to open the call for questions from the audience.